SPDR S&P Biotech ETF Options Spot-On: On January 14th, 92,360 Contracts Were Traded, With 927.64K Open Interest

On January 14th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 92,360 options for the day, of which put options accounted for 69.71% of the total

Futu News05:30

On the first day of the JPM Medical Conference, pharmaceutical giants are announcing new strategies. Could the mergers and acquisitions in Biomedical begin in 2025?

In 2025, the Biomedical mergers and acquisitions will begin.

wallstreetcnJan 14 19:01

SPDR S&P Biotech ETF Options Spot-On: On January 13th, 93,959 Contracts Were Traded, With 948.11K Open Interest

On January 13th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 93,959 options for the day, of which put options accounted for 61.69% of the total

Futu NewsJan 14 05:30

SPDR S&P Biotech ETF Options Spot-On: On January 10th, 145.75K Contracts Were Traded, With 889.49K Open Interest

On January 10th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 145.75K options for the day, of which put options accounted for 61.16% of the total

Futu NewsJan 11 05:30

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

BenzingaJan 9 01:54

Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer

Seeking AlphaJan 4 00:21